Mostrar el registro sencillo del ítem

Artículo

dc.creatorSchnitzler, A.es
dc.creatorMir Rivera, Pabloes
dc.creatorBrodsky, M. A.es
dc.creatorVerhagen, L.es
dc.creatorGroppa, S.es
dc.creatorÁlvarez, R.es
dc.creatorVesper, J.es
dc.date.accessioned2022-10-28T15:33:45Z
dc.date.available2022-10-28T15:33:45Z
dc.date.issued2021
dc.identifier.citationSchnitzler, A., Mir Rivera, P., Brodsky, M.A., Verhagen, L., Groppa, S., Álvarez, R. y Vesper, J. (2021). Directional deep brain stimulation for Parkinson's disease: results of an international crossover study with randomized, double-blind primary endpoint. Neuromodulation. https://doi.org/10.1111/ner.13407.
dc.identifier.issn1094-7159es
dc.identifier.urihttps://hdl.handle.net/11441/138479
dc.description.abstractObjective: Published reports on directional deep brain stimulation (DBS) have been limited to small, single-center investigations. Therapeutic window (TW) is used to describe the range of stimulation amplitudes achieving symptom relief without side effects. This crossover study performed a randomized double-blind assessment of TW for directional and omnidirectional DBS in a large cohort of patients implanted with a DBS system in the subthalamic nucleus for Parkinson’s disease. Materials and Methods: Participants received omnidirectional stimulation for the first three months after initial study pro gramming, followed by directional DBS for the following three months. The primary endpoint was a double-blind, randomized evaluation of TW for directional vs omnidirectional stimulation at three months after initial study programming. Additional data recorded at three- and six-month follow-ups included stimulation preference, therapeutic current strength, Unified Parkinson’s Disease Rating Scale (UPDRS) part III motor score, and quality of life. Results: The study enrolled 234 subjects (62 ± 8 years, 33% female). TW was wider using directional stimulation in 183 of 202 subjects (90.6%). The mean increase in TW with directional stimulation was 41% (2.98 ± 1.38 mA, compared to 2.11 ± 1.33 mA for omnidirectional). UPDRS part III motor score on medication improved 42.4% at three months (after three months of omnidi rectional stimulation) and 43.3% at six months (after three months of directional stimulation) with stimulation on, compared to stimulation off. After six months, 52.8% of subjects blinded to stimulation type (102/193) preferred the period with directional stimulation, and 25.9% (50/193) preferred the omnidirectional period. The directional period was preferred by 58.5% of clinicians (113/193) vs 21.2% (41/193) who preferred the omnidirectional period. Conclusion: Directional stimulation yielded a wider TW compared to omnidirectional stimulation and was preferred by blinded subjects and clinicians.es
dc.formatapplication/pdfes
dc.format.extent12 p.es
dc.language.isoenges
dc.publisherBlackwell Publishing INCes
dc.relation.ispartofNeuromodulation.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDeep brain stimulationes
dc.subjectDirectional programminges
dc.subjectParkinson’s diseasees
dc.subjectTherapeutic windowes
dc.titleDirectional deep brain stimulation for Parkinson's disease: results of an international crossover study with randomized, double-blind primary endpointes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S1094715921064230?via%3Dihubes
dc.identifier.doi10.1111/ner.13407es
dc.contributor.groupUniversidad de Sevilla. CTS630: Trastornos del Movimientoes
dc.journaltitleNeuromodulationes

FicherosTamañoFormatoVerDescripción
Directional...pdf1.074MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional